BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27926516)

  • 1. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
    Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
    Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
    Zhang QH; Dai XH; Dai ZM; Cai YN
    Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
    Yuan S; Yu Z; Liu Q; Zhang M; Xiang Y; Wu N; Wu L; Hu Z; Xu B; Cai T; Ma X; Zhang Y; Liao C; Wang L; Yang P; Bai L; Li Y
    Oncogene; 2016 Nov; 35(47):6120-6131. PubMed ID: 27157618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers.
    Tessema M; Yingling CM; Liu Y; Tellez CS; Van Neste L; Baylin SS; Belinsky SA
    Carcinogenesis; 2014 Jun; 35(6):1248-57. PubMed ID: 24398667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent aberrant methylation of the promoter region of sterile alpha motif domain 14 in pulmonary adenocarcinoma.
    Sun W; Iijima T; Kano J; Kobayashi H; Li D; Morishita Y; Okubo C; Anami Y; Noguchi M
    Cancer Sci; 2008 Nov; 99(11):2177-84. PubMed ID: 18823374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers.
    Imoto I; Izumi H; Yokoi S; Hosoda H; Shibata T; Hosoda F; Ohki M; Hirohashi S; Inazawa J
    Cancer Res; 2006 May; 66(9):4617-26. PubMed ID: 16651412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.
    Tessema M; Willink R; Do K; Yu YY; Yu W; Machida EO; Brock M; Van Neste L; Stidley CA; Baylin SB; Belinsky SA
    Cancer Res; 2008 Mar; 68(6):1707-14. PubMed ID: 18339850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel approach, the epigenome-based outlier approach, to identify tumor-suppressor genes silenced by aberrant DNA methylation.
    Kikuyama M; Takeshima H; Kinoshita T; Okochi-Takada E; Wakabayashi M; Akashi-Tanaka S; Ogawa T; Seto Y; Ushijima T
    Cancer Lett; 2012 Sep; 322(2):204-12. PubMed ID: 22433712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
    Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
    Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
    Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
    Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
    Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer.
    Liu WB; Han F; Jiang X; Chen HQ; Zhao H; Liu Y; Li YH; Huang C; Cao J; Liu JY
    Oncotarget; 2015 Aug; 6(25):21225-39. PubMed ID: 26056045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
    Tessema M; Yingling CM; Picchi MA; Wu G; Ryba T; Lin Y; Bungum AO; Edell ES; Spira A; Belinsky SA
    Cancer Lett; 2017 Dec; 410():191-200. PubMed ID: 28965852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetically Silenced Candidate Tumor Suppressor Genes in Prostate Cancer: Identified by Modeling Methylation Stratification and Applied to Progression Prediction.
    Zhang W; Flemington EK; Deng HW; Zhang K
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):198-207. PubMed ID: 30262601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.